NCT05113498View on ClinicalTrials.gov

The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-ols

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

April 26, 2022

Study Completion Date

April 26, 2022

Conditions
Diet Modification
Interventions
DIETARY_SUPPLEMENT

(-)-Epicatechin

Administration of a capsule with 150 mg of pure (-)-epicatechin after 48h low-flavanol diet.

Trial Locations (1)

9000

University Ghent, Ghent

All Listed Sponsors
lead

University Ghent

OTHER

NCT05113498 - The Influence of the Microbiome on the Pharmacokinetics of Flavan-3-ols | Biotech Hunter | Biotech Hunter